[1-(methoxymethyl)pyrazol-4-yl]boronic acid

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: [1-(methoxymethyl)pyrazol-4-yl]boronic acid
• 英文别名: (1-(Methoxymethyl)-1H-pyrazol-4-yl)boronic acid
• 化学式: C₅H₉BN₂O₃
• 分子量: 155.949
• InChiKey: SYZGLBMYJAQKHV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -1.83
• 重原子数：
  11
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  67.5
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  [1-(methoxymethyl)pyrazol-4-yl]boronic acid 、 4-benzyloxy-3-bromo-2-(4-tert-butyl-5-chloro-2-methylphenyl)-5,6-dimethylpyridine 在 potassium phosphate 、 dichloro[1,1'-bis(di-t-butylphosphino)ferrocene]palladium(II) 作用下， 以 1,4-二氧六环 、 水 为溶剂， 生成 4-benzyloxy-2-(4-tert-butyl-5-chloro-2-methylphenyl)-3-[1-(methoxymethyl)pyrazol-4-yl]-5,6-dimethylpyridine
  参考文献：
  名称：

  [EN] HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN
  [FR] COMPOSÉS HÉTÉROARYLES POUR LE TRAITEMENT DE LA DOULEUR

  摘要：

  Compounds, and pharmaceutically acceptable salts thereof, useful as inhibitors of sodium channels are provided. Also provided are pharmaceutical compositions comprising the compounds or pharmaceutically acceptable salts and methods of using the compounds, pharmaceutically acceptable salts, and pharmaceutical compositions in the treatment of various disorders, including pain.

  公开号：

  WO2023205465A1

文献信息

• [EN] HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN<br/>[FR] COMPOSÉS HÉTÉROARYLES POUR LE TRAITEMENT DE LA DOULEUR
  申请人：[en]VERTEX PHARMACEUTICALS INCORPORATED

  公开号：WO2023205465A1

  公开（公告）日：2023-10-26

  Compounds, and pharmaceutically acceptable salts thereof, useful as inhibitors of sodium channels are provided. Also provided are pharmaceutical compositions comprising the compounds or pharmaceutically acceptable salts and methods of using the compounds, pharmaceutically acceptable salts, and pharmaceutical compositions in the treatment of various disorders, including pain.